XML 34 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
Financial Instruments and Risk Management
12 Months Ended
Dec. 31, 2015
Investments All Other Investments [Abstract]  
Financial Instruments and Risk Management

NOTE 12 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT:

 

a.

General

The Company operates internationally, which gives rise to exposure to market risks, mainly from changes in foreign exchange rates.  The Company uses financial instruments and derivatives to hedge its balance sheet exposures as well as certain future cash flows in connection with payroll and related expenses and anticipated probable transactions which are expected to be denominated in non-Dollar currencies.

The Company is exposed to losses in the event of non-performance by counterparties to financial instruments; however, as the counterparties are major Israeli, European and United States banks, the Company does not expect any counterparties to fail to meet their obligations.  The Company does not require or place collateral with respect to these financial instruments.  The Company does not hold or issue derivatives for trading purposes.

NOTE 12 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (continued):

 

b.

Derivative instruments

As stated in Note 1s, the Company enters into various types of foreign exchange derivatives in managing its foreign exchange risks.  The notional amounts of these derivatives as of December 31, 2015 were as follows:

 

 

 

$ in millions

 

Forward exchange and options for conversion of:

 

 

 

 

Euros into Dollars

 

 

16.6

 

Japanese Yen into Dollars

 

 

63.7

 

Dollars into NIS

 

 

17.9

 

Korean Won into Dollars

 

 

18.2

 

Chinese Yuan into Dollars

 

 

15.6

 

Taiwan Dollars into Dollars

 

 

20.5

 

Dollars into British Pounds

 

 

90.5

 

 

The term of most of these currency derivatives are less than one year.

The following table summarizes activity in accumulated other comprehensive income (loss) related to derivatives classified as foreign currency cash flow hedges held by the Company during the reported years:

 

 

 

Year ended December 31

 

 

 

2015

 

 

2014

 

 

2013

 

 

 

$ in thousands

 

Balance at beginning of year

 

 

(1,928

)

 

 

409

 

 

 

628

 

Unrealized gains (losses) from derivatives

 

 

(4,155

)

 

 

(2,364

)

 

 

2,050

 

Reclassifications into earnings from other

   comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

included in revenues

 

 

(249

)

 

 

(1,917

)

 

 

(809

)

included in various statements of operations items

 

 

4,969

 

 

 

1,667

 

 

 

(1,519

)

Tax effect

 

 

(115

)

 

 

277

 

 

 

59

 

Balance at end of year

 

 

(1,477

)

 

 

(1,928

)

 

 

409

 

 

 

c.

Fair value of financial instruments

The fair value of financial instruments included in working capital is usually close or identical to their carrying amounts.  The fair value of non-current other receivables and long-term liabilities, including long term loans, also approximates the carrying amounts, since they bear interest at rates close to prevailing market rates.

NOTE 12 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (continued):

The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2015 and 2014, consistent with the fair value hierarchy provisions of the applicable accounting rules:

 

 

 

Level 1

 

 

Level 2

 

 

Total

 

December 31, 2015:

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities

 

 

6,046

 

 

 

—  

 

 

 

6,046

 

Derivative assets not designated as hedging

   instruments

 

 

—  

 

 

 

288

 

 

 

288

 

Liabilities -

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liabilities designated as hedging

   instruments

 

 

—  

 

 

 

1,486

 

 

 

1,486

 

Derivative liabilities not designated as hedging

   instruments

 

 

—  

 

 

 

457

 

 

 

457

 

December 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities

 

 

5,890

 

 

 

 

 

 

 

5,890

 

Derivative assets not designated as hedging

   instruments

 

 

 

 

 

 

1,665

 

 

 

1,665

 

Liabilities -

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liabilities designated as hedging

   instruments

 

 

 

 

 

 

1,891

 

 

 

1,891

 

Derivative liabilities not designated as hedging

   instrument

 

 

 

 

 

 

218

 

 

 

218

 

 

 

1.

Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

2.

Level 2 - Valuations based on quoted prices in markets that are not active but for which all significant inputs are observable, either directly or indirectly.  Derivatives, as described in b. above, are of value primarily based on observable inputs including interest rate curves and both forward and spot prices for currencies and the Company is therefore able to perform independent verification in order to validate quotations obtained.

 

3.

Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.  These estimated fair values are subject to uncertainties that are difficult to predict.